FrancophonIA/ELRC3.0 huggingface dataset:
English: See Table 1 for the recommended preparation and administration of Levetiracetam SUN concentrate for solution for infusion to achieve a total daily dose of 500 mg, 1000 mg, 2000 mg, or 3000 mg in two divided doses.
Slovenian: Glejte Preglednico 1 za priporočeno pripravo in uporabo Levetiracetama SUN koncentrat za raztopino za infundiranje, da se doseže celokupni dnevni odmerek 500 mg, 1.000 mg, 2.000 mg ali 3.000 mg razdeljen na dva odmerka.
English: (2) Dose in children and adolescents 50 kg or more is the same as in adults.
Slovenian: Pri otrocih in mladostnikih, s telesno maso 50 kg ali več, je odmerjanje enako kot pri odraslih.
English: How Levetiracetam SUN is given
Slovenian: Kako se daje zdravilo Levetiracetam SUN
English: Adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
Slovenian: Dopolnilno zdravljenje miokloničnih napadov pri odraslih in mladostnikih, od 12. leta starosti, z juvenilno mioklonično epilepsijo.
English: Levetiracetam SUN contains sodium
Slovenian: Zdravilo Levetiracetam SUN vsebuje natrij
English: (1) A 15 mg/kg (0.15 ml/kg) loading dose is recommended on the first day of treatment with levetiracetam.
Slovenian: (1) Prvi dan zdravljenja z levetiracetamom je priporočen začetni odmerek 15 mg/kg (0,15 ml/kg).
English: Levetiracetam has been given to you by your doctor to reduce the number of fits - with other antiepileptic medicines (add-on therapy) to treat: partial onset seizures with or without generalisation in adults, adolescents and children from 4 years of age myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in adults and adolescents from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).
Slovenian: - kot dopolnilo drugim protiepileptičnim zdravilom za zdravljenje: parcialnih napadov z generalizacijo ali brez nje odraslih, mladostnikih in otrocih od 4. leta starosti miokloničnih napadov (kratki, nenadni trzaji mišice ali skupine mišic) pri odraslih in mladostnikih od 12. leta starosti z juvenilno mioklonično epilepsijo primarno generaliziranih tonično-kloničnih napadov (veliki napadi, vključno z izgubo zavesti) pri odraslih in mladostnikih od 12. leta starosti z idiopatsko generalizirano epilepsijo (oblika epilepsije, za katero se domneva, da je genetskega izvora).
English: In this study, levetiracetam, dose was 3000 mg/day given in 2 divided doses.
Slovenian: V tej študiji je bil odmerek levetiracetama 3.000 mg na dan, razdeljen na dva odmerka.
English: The NOAEL (No Observed Adverse Effect Level) was 3600 mg/kg/day for pregnant female rats (x 12 the MRHD on a mg/m2 basis) and 1200 mg/kg/day for fetuses.
Slovenian: Odmerek, pri katerem ni mogoče opaziti neželenih učinkov (NOAEL), je bil pri brejih podganah 3.600 mg/kg/dan (12-kratna vrednost največjega priporočenega odmerka pri ljudeh glede na mg/m2) in pri plodovih1.200 mg/kg/dan.
English: Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy:
Slovenian: Dopolnilno zdravljenje parcialnih napadov s sekundarno generalizacijo ali brez nje pri odraslih, mladostnikih in otrocih, od 4. leta starosti, z epilepsijo
English: Levetiracetam SUN is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Slovenian: Zdravilo Levetiracetam SUN je indicirano za samostojno zdravljenje parcialnih napadov s sekundarno generalizacijo ali brez nje pri odraslih in mladostnikih od 16. leta starosti, z na novo diagnosticirano epilepsijo.
English: The NOAEL was <200 mg/kg/day for the dams and 200 mg/kg/day for the fetuses (equal to the MRHD on a mg/m2 basis).
Slovenian: Odmerek, pri katerem ni mogoče opaziti neželenih učinkov (NOAEL), je bil < 200 mg/kg/dan za samice in 200 mg/kg/dan za plodove (je enako največjemu priporočenemu odmerku pri ljudeh glede na mg/m2).
English: Each ml contains 100 mg of levetiracetam.
Slovenian: Vsak ml vsebuje 100 mg levetiracetama.
English: Marketing Authorisation Holder and Manufacturer Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87
Slovenian: Imetnik dovoljenja za promet z zdravilom in proizvajalec Sun Pharmaceutical Industries Europe B.V.
English: Blood methotrexate and levetiracetam levels should be carefully monitored in patients treated concomitantly with the two drugs
Slovenian: Pri bolnikih, ki se sočasno zdravijo z obema učinkovinama, je potrebno skrbno spremljanje koncentracije metotreksata in levetiracetama v krvi.
English: Other ingredients include sodium acetate trihydrate, glacial acetic acid, sodium chloride, water for injection.
Slovenian: Pomožne snovi so natrijev trihidrat acetat, koncentrirana ocetna kislina, natrijev klorid, voda za injekcije.
English: Neonatal and juvenile animal studies in rats and dogs demonstrated that there were no adverse effects seen in any of the standard developmental or maturation endpoints at doses up to 1800 mg/kg/day (x 6-17 the MRHD on a mg/m2 basis).
Slovenian: V študijah pri novoskotenih živalih in mladičih živali so dokazali, da pri podganah in psih, pri odmerkih do 1.800 mg/kg/dan (6-kratna do 17-kratna vrednost največjega priporočenega odmerka pri ljudeh glede na mg/m2) ni bilo neželenih učinkov na standardne parametre razvoja in dozorevanja.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Levetiracetam SUN 100 mg/ml sterile concentrate levetiracetam
Slovenian: IME ZDRAVILA IN POT(I) UPORABE Levetiracetam SUN 100 mg/ml sterilni koncentrat levetiracetam IV
English: confusion, panic attack, emotional instability/mood swings, agitation - amnesia (loss of memory), memory impairment (forgetfulness), abnormal coordination/ataxia
Slovenian: agitacija (motorični nemir) - amnezija (izguba spomina), oslabljen spomin (pozabljivost), poslabšana koordinacija/ataksija
English: Deutschland Sun Pharmaceuticals Germany GmbH
Slovenian: Sun Pharmaceuticals Germany GmbH Hemmelrather Weg 201
English: Preparation and administration of Levetiracetam SUN concentrate
Slovenian: Preglednica 1: Priprava in uporaba koncentrata zdravila Levetiracetam SUN
English: Children from 4 years and adolescents weighing less than 50 kg
Slovenian: Otroci, starejši od 4 let, in mladostniki, s telesno maso manj kot 50 kg normalno delovanje ledvic
English: The safety and efficacy of Levetiracetam SUN in children below and adolescents 16 years as monotherapy treatment have not been established.
Slovenian: Pri samostojnem zdravljenju pri otrocih in mladostnikih, mlajših od 16 let, varnost in učinkovitost zdravila Levetiracetam SUN nista bili dokazani.
English: STATEMENT OF ACTIVE SUBSTANCE(S) One vial contains 500 mg/5 ml levetiracetam.
Slovenian: NAVEDBA ENE ALI VEČ UČINKOVIN Ena viala vsebuje 500 mg/5 ml levetiracetama.
English: Common: may affect up to 1 in 10 people - anorexia (loss of appetite) - depression, hostility or aggression, anxiety, insomnia, nervousness or irritability - convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness),
Slovenian: Pogosti: pojavijo se lahko pri največ 1 od 10 bolnikov - anoreksija (izguba teka) - depresija, sovražnost ali agresivnost, tesnoba, nespečnost, živčnost ali razdražljivost - konvulzije, motnje ravnotežja, omotica (občutek nesigurnosti), letargija (pomanjkanje energije in navdušenja), tremor (nehoteno tresenje) - vrtoglavica (občutek vrtenja) - kašelj - bolečina v trebuhu, driska, dispepsija (slaba prebava), bruhanje, slabost - izpuščaj - astenija/izčrpanost (utrujenost)
English: PHARMACEUTICAL FORM AND CONTENTS 500 mg/5 ml
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA 500 mg/5 ml 10 vial koncentrata za raztopino za infundiranje
English: 1500 mg 15 ml (three 5 ml vials) 100 ml
Slovenian: 1.500 mg 15 ml (tri 5 ml viale) 100 ml
English: Abdominal pain, diarrhoea, dyspepsia, vomiting, nausea
Slovenian: Bolezni prebavil bolečina v trebuhu, driska, dispepsija, bruhanje, navzeja pankreatitis
English: Rare: may affect up to 1 in 1,000 people - infection - decreased number of all blood cell types - severe allergic reactions (DRESS, anaphylactic reaction [severe and important allergic reaction], Quincke's oedema [swelling of the face, lips, tongue and throat])) - decreased blood sodium concentration - suicide, personality disorders (behavioural problems), thinking abnormal (slow thinking, unable to concentrate) - delirium - encephalopathy (see sub-section “Tell your doctor immediately” for a detailed description of symptoms) - uncontrollable muscle spasms affecting the head, torso and limbs, difficulty in controlling movements, hyperkinesia (hyperactivity) - pancreatitis - liver failure, hepatitis - sudden decrease in kidney function - skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (StevensJohnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis) rhabdomyolysis (breakdown of muscle tissue) and associated blood creatine phosphokinase increase.
Slovenian: nezmožnost koncentracije) - delirij - encefalopatija (glejte podpoglavje »Takoj obvestite zdravnika« za podroben opis simptomov) - nekontrolirani mišični spazmi, ki prizadanejo glavo, trup in okončine, težave pri nadzoru gibanja, hiperkinezija (hiperaktivnost) - vnetje trebušne slinavke - odpoved jeter, hepatitis - nenadno zmanjšanje delovanja ledvic - kožni izpuščaj, ki lahko tvori mehurčke in izgleda kot majhne tarče (na sredini temne pike obkrožene s svetlejšim delom in s temnim krogom na robu) (multiformni eritem), široko razširjen izpuščaj z mehurčki in luščenjem kože, še posebej okoli ust, nosu, oči in v predelu spolovil (Stevens-Johnsonov sindrom) in bolj huda oblika, ki povzroči luščenje kože na več kot
English: Suicide attempt, suicidal ideation, psychotic disorder, abnormal behaviour, hallucination, anger, confusional state, panic attack, affectlability/mood swings, agitation
Slovenian: Psihiatrične motnje depresija, sovražnost/ agresivnost, anksioznost, nespečnost, živčnost/razdražljivost poskus samomora, razmišljanje o samomoru, psihotične motnje, nenormalno vedenje, halucinacije, jeza, stanje zmedenosti , napad panike, čustvena labilnost/nihanja v razpoloženju, agitacija samomor), osebnostne motnje, motnje mišljenja, delirij
English: necrolysis, Stevens-Johnson syndrome, erythema multiforme
Slovenian: Bolezni kože in podkožja izpuščaj alopecija, ekcem, pruritus toksična epidermalna nekroliza, StevensJohnsonov sindrom, multiformni eritem
English: Each vial contains 19 mg of sodium For the full list of excipients, see section 6.1.
Slovenian: Za celoten seznam pomožnih snovi glejte poglavje 6.1.
English: 250 mg 2.5 ml (half 5 ml vial)
Slovenian: 250 mg 2,5 ml (pol 5 ml viale) 100 ml
English: Rhabdomyolysis and blood creatine phosphokinase increased*
Slovenian: Redki sistema in vezivnega tkiva fosfokinaze v krvi*
English: No dose adjustment is needed in patients with mild to moderate hepatic impairment.
Slovenian: Pri bolnikih z blago do zmerno jetrno okvaro odmerka ni potrebno prilagajati.
English: Other medicines and Levetiracetam SUN
Slovenian: Shranjevanje zdravila Levetiracetam SUN
English: Each carton contains 10 vials.
Slovenian: Viale so v škatlah po 10.
English: 1000 mg 10 ml (two 5 ml vials)
Slovenian: 1.000 mg 10 ml (dve 5 ml viali) 100 ml
English: Muscular weakness, myalgia
Slovenian: Bolezni mišičnoskeletnega mišična oslabelost, mialgija rabdomioliza in zvišanje kreatin
English: undergoing dialysis (1) (1) A 750 mg loading dose is recommended on the first day of treatment with levetiracetam.
Slovenian: Prvi dan zdravljenja z levetiracetamom je priporočljiv začetni odmerek 750 mg.
English: Blood and lymphatic system disorders
Slovenian: Bolezni krvi in limfatičnega sistema trombocitopenija levkopenija pancitopenija nevtropenija, agranulocitoza
English: 15 minutes Twice daily 500 mg/day
Slovenian: 15 minut dvakrat na dan 500 mg/dan
English: Preparation and administration of Levetiracetam SUN concentrate for solution for infusion
Slovenian: Preglednico 1: Priprava in uporaba Levetiracetama SUN koncentrat za raztopino za infundiranje
English: Duration of treatment
Slovenian: Dopolnilno zdravljenje
English: Levetiracetam SUN concentrate for solution for infusion is packed in a cardboard box containing 10 vials of 5 ml.
Slovenian: 5 ml viale zdravila Levetiracetam SUN koncentrat za raztopino za infundiranje so pakirane v škatle po 10 skupaj.
English: 15 minutes Twice daily 3000 mg/day
Slovenian: 15 minut dvakrat na dan 3.000 mg/dan
English: No adverse reactions on male or female fertility or reproduction performance were observed in rats at doses up to 1800 mg/kg/day (x 6 the MRHD on a mg/m2 or exposure basis) in parents and F1 generation.
Slovenian: Pri podganah, starševska in F1 generacija, pri odmerkih do 1.800 mg/kg/dan (6-kratna vrednost največjega priporočenega odmerka pri ljudeh glede na mg/m2 ali na osnovno izpostavljenost) niso opazili neželenih učinkov na plodnost samcev ali samic ali na razmnoževanje.
English: Infections and infestations
Slovenian: Infekcijske in parazitske bolezni nazofaringitis okužba
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam SUN 100 mg/ml concentrate for solution for infusion
Slovenian: IME ZDRAVILA Levetiracetam SUN 100 mg/ml koncentrat za raztopino za infundiranje
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial of 5 ml
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH
English: The NOAEL was ≥ 1800 mg/kg/day for the F0 females, and for the survival, growth and development of the F1 offspring up to weaning.
Slovenian: Odmerek, pri katerem ni mogoče opaziti neželenih učinkov (NOAEL) je bil ≥1.800 mg/kg/dan tako za F0 samice kot za preživetje, rast in razvoj F1 mladičev do prenehanja dojenja (6-kratna vrednost največjega priporočenega odmerka pri ljudeh glede na mg/m2).
English: IV
Slovenian: B.
English: Dose changes can be made in 500 mg twice daily increases or decreases every two to four weeks.
Slovenian: Na vsaka 2 tedna do 4 tedne lahko odmerek povečamo ali zmanjšamo za 500 mg dvakrat na dan. Trajanje zdravljenja
English: Therefore, the interaction of levetiracetam with other substances, or vice versa, is unlikely.
Slovenian: Prehod od filmsko obloženih tablet ali od peroralne raztopine k intravenski obliki ali obratno je lahko neposreden brez prilagajanja odmerka.
English: Depression, hostility/ aggression, anxiety, insomnia, nervousness/irritability
Slovenian: halucinacije, jeza, zmedenost, napad panike, čustvena nestabilnost/nihanja v razpoloženju,
English: 15 minutes Twice daily 1000 mg/day
Slovenian: 15 minut dvakrat na dan 1.000 mg/dan
English: 15 minutes Twice daily 2000 mg/day
Slovenian: 15 minut dvakrat na dan 2.000 mg/dan
English: NAME OF THE MEDICINAL PRODUCT Levetiracetam SUN 100 mg/ml concentrate for solution for infusion levetiracetam
Slovenian: Navodilo za uporabo Levetiracetam SUN 100 mg/ml koncentrat za raztopino za infundiranje levetiracetam
English: Talk to your doctor before you are given Levetiracetam SUN - If you suffer from kidney problems, follow your doctor's instructions.
Slovenian: Pred začetkom jemanja zdravila Leveratiracetam SUN se posvetujte z zdravnikom.
English: Package Leaflet: Information for the patient Levetiracetam SUN 100 mg/ml concentrate for solution for infusion levetiracetam
Slovenian: PODATKI NA ZUNANJI OVOJNINI Škatla z 10 vialami IME ZDRAVILA Levetiracetam SUN 100 mg/ml koncentrat za raztopino za infundiranje levetiracetam
English: Starting dose: 10 mg/kg twice daily
Slovenian: Priporočeno odmerjanje za otroke in mladostnike: telesna masa začetni odmerek: 10 mg/kg dvakrat na dan največji odmerek: 30 mg/kg dvakrat na dan
English: 100 ml
Slovenian: Viala po 5 ml
English: EXPIRY DATE
Slovenian: Kubickiego 11
English: Food enhances the absorption.
Slovenian: Dajanje s hrano izboljša absorpcijo.
English: These signs typically resolve without treatment.
Slovenian: Ti znaki običajno izginejo brez zdravljenja.
English: ATCvet code: QP53BE04
Slovenian: Oznaka ATC vet: QP53BE04
English: The terminal half-life is approximately 4 weeks.
Slovenian: Končni razpolovni čas je približno 4 tedne.
English: 10 DATE OF REVISION OF THE TEXT <{DD/MM/YYYY}>
Slovenian: DATUM REVIZIJE BESEDILA <{DD/MM/LLLL}>
English: Appropriate combination of tablets
Slovenian: Ustrezna kombinacija tablet
English: Due to insufficient data to support efficacy against ticks in young cats, this product is not recommended for the treatment of ticks in kittens 5 months of age or younger.
Slovenian: Zaradi nezadostnih podatkov, ki bi podpirali učinkovitost proti klopom pri mladih mačkah, uporaba tega zdravila ni priporočljiva za zdravljenje infestacij s klopi pri mačjih mladičih, starih 5 mesecev ali manj.
English: The terminal half-life is approximately 4 weeks (harmonic mean).
Slovenian: Končni razpolovni čas je približno 4 tedne (harmonična sredina).
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 25/04/2017
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 25/04/2017
English: Wash hands after handling the product.
Slovenian: Po uporabi zdravila si umijte roke.
English: During clinical testing, no interactions between Credelio chewable tablets and routinely used veterinary medicinal products were observed.
Slovenian: V kliničnem preskušanju niso opazili nobenega medsebojnega delovanja med Credelio žvečljivimi tabletami in zdravili, ki se rutinsko uporabljajo v veterinarski medicini.
English: Strength and number of tablets to be administered Credelio 12 mg
Slovenian: Jakost in število tablet, ki jih je treba dati Credelio 12 mg
English: Lotilaner is approximately 10 times more bioavailable when administered with food.
Slovenian: Biološka uporabnost lotilanerja je približno 10-krat večja, če se zdravilo daje skupaj s hrano.
English: Elanco
Slovenian: KARENCA
English: Administer the chewable tablet(s) monthly with or after food.
Slovenian: Žvečljivo(e) tableto(e) dajte vsak mesec s hrano ali po njej.
English: Acceptable levels of efficacy may not be achieved if the veterinary medicinal product is not administered with food or within 30 minutes after feeding.
Slovenian: Sprejemljive ravni učinkovitosti morda ne bodo dosežene, če se zdravilo za uporabo v veterinarski medicini ne da skupaj s hrano ali v 30 minutah po hranjenju.
English: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Slovenian: - občasni (pri več kot 1, toda manj kot 10 živalih od 1.000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živalih od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri)
English: Parasites need to start feeding on the host to become exposed to lotilaner; therefore the risk of the transmission of parasite borne diseases cannot be completely excluded.
Slovenian: Zajedavci so izpostavljeni lotilanerju šele, ko se začnejo hraniti na gostitelju, zato tveganja prenosa zajedavskih bolezni ni mogoče popolnoma izključiti.
English: For optimal control of tick and flea infestations, the veterinary medicinal product should be administered at monthly intervals and continued throughout the flea and/or tick season based on local epidemiological situations.
Slovenian: Za optimalen nadzor infestacij z bolhami in klopi je treba zdravilo za uporabo v veterinarski medicini dajati v enomesečnih intervalih in dajanje nadaljevati skozi celotno sezono bolh in/ali klopov na podlagi lokalnih epidemioloških situacij.
English: In case of accidental ingestion, seek medical advice immediately and show the package leaflet or label to the physician.
Slovenian: V primeru nenamernega zaužitja se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
English: Credelio 900 mg chewable tablets for dogs: 2 years
Slovenian: Credelio 900 mg žvečljive tablete za pse: 2 leti
English: Lotilaner is a potent inhibitor of gamma-aminobutyric acid (GABA)-gated chloride channels, resulting in rapid death of ticks and fleas.
Slovenian: Lotilaner močno zavira klorove kanalčke, ki jih proži gama-aminobutirična kislina (GABA), s čimer povzroči hitro smrt klopov in bolh.
English: STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Each chewable tablet contains: Credelio chewable tablets lotilaner (mg)
Slovenian: NAVEDBA UČINKOVIN(E) IN DRUGIH SESTAVIN Vsaka žvečljiva tableta vsebuje: Credelio žvečljive tablete lotilaner (mg)
English: Lotilaner is metabolized to a small extent into more hydrophilic compounds which are observed in faeces and urine.
Slovenian: Lotilaner se v majhni meri metabolizira v bolj hidrofilne spojine, ki so jih ugotovili v blatu in urinu.
English: Elanco France S.A.S 26 Rue de la Chapelle 68330 Huningue FRANCE
Slovenian: Elanco France S.A.S., 26 rue de la Chapelle, 68330 Huningue, Francija
English: The veterinary medicinal product should be administered in accordance with the following table to ensure a dose of 20 to 43 mg lotilaner/kg bodyweight.
Slovenian: Zdravilo za uporabo v veterinarski medicini je treba dati v skladu z naslednjo razpredelnico, da se zagotovi odmerek od 20 do 43 mg lotilanerja/kg telesne mase.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/17/206/016-21
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/17/206/016-21
English: NAME OF THE VETERINARY MEDICINAL PRODUCT Credelio 12 mg (0.5-2.0 kg)
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Credelio 12 mg (0,5-2,0 kg)
English: 56 mg lotilaner 112 mg lotilaner 225 mg lotilaner 450 mg lotilaner 900 mg lotilaner
Slovenian: 56 mg lotilanerja 112 mg lotilanerja 225 mg lotilanerja 450 mg lotilanerja 900 mg lotilanerja
English: Credelio chewable tablets lotilaner (mg)
Slovenian: Credelio žvečljive tablete lotilaner (mg)
English: Body weight of cat (kg)
Slovenian: Telesna masa mačke (kg)
English: The tablets are packaged in aluminium/aluminium blisters packaged into an outer cardboard box.
Slovenian: Tablete so pakirane v pretisne omote iz aluminija/aluminija in zunanjo kartonsko škatlo.
English: The veterinary medicinal product kills existing and newly emerged fleas on cats before they can lay eggs.
Slovenian: Zdravilo za uporabo v veterinarski medicini uničuje že prisotne in nove bolhe na mačkah, preden lahko izležejo jajčeca.
English: 48 mg lotilaner
Slovenian: 12 mg lotilanerja 48 mg lotilanerja
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton box and blister after EXP.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na kartonski škatli in pretisnem omotu za oznako »EXP«.
English: Existing I. ricinus ticks on the animal prior to administration are killed within 8 hours.
Slovenian: Klopi I. ricinus, ki so prisesani že pred dajanjem zdravila, so uničeni v 8 urah.
English: The veterinary medicinal product kills existing and newly emerged fleas on dogs before they can lay eggs.
Slovenian: Zdravilo za uporabo v veterinarski medicini uničuje že prisotne in nove bolhe na psih, preden lahko izležejo jajčeca.
English: Pharmacotherapeutic group: ectoparasiticides for systemic use, isoxazolines.
Slovenian: Farmakoterapevtska skupina: učinkovine proti ektoparazitom za sistemsko zdravljenje, izoksazolini.